pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4433a |
Genomic Coordinates | chr2: 64340759 - 64340839 |
Description | Homo sapiens miR-4433a stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4433a-3p | ||||||||||||
Sequence | 51| ACAGGAGUGGGGGUGGGACAU |71 | ||||||||||||
Evidence | Experimental | ||||||||||||
Experiments | Illumina | ||||||||||||
SNPs in miRNA |
|
||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | C5orf51 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | chromosome 5 open reading frame 51 | ||||||||||||||||||||
Transcript | NM_175921 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on C5orf51 | |||||||||||||||||||||
3'UTR of C5orf51 (miRNA target sites are highlighted) |
>C5orf51|NM_175921|3'UTR 1 TAAGTTCATCTAGTCCTTTTCAAATAGAAAAACAACAAAACCCATGAAATGGAAAAGAGAGTTCCAAAAAAGAAGACCTG 81 TTGATACTGAATATGAGAACATTACACTGCATAAAGATATCCAGCTTGGGTACCCTACTAAAACAACATCACCATCTTTT 161 TCATTATATATTAGTAAACCTATGAAGGGATGATTCTTTAATTTCTAAAGTGTTGTTCAAACTCACCTTAAAATACAGAT 241 GTTATGTCACTAATAATGAGTAGTAACCCAATTTAGCTTTACAAAGATTTTTTCTATTACTTTTTTTTTTTATTGTGGTA 321 TATGTAACACAAGTTTACCATTTTTATCATCTTTAGATTATTTTTAAATCTCACTACCTTGAAGTTTGCCATGCTTCAGA 401 AATTAAAGTCAAGTTACTTCACTGCTTTGAATACATACTATGGATATAAATGTAGGCAAAATGAAAGATTATGACTAATA 481 TTCAGATTCCATTTTCAATAAGGTAAATAATGAAAGATCTCACAAAGGAATCATTGTGTTTAATTATTTTGCCATGTATT 561 ACTAATTGTATTTAAAATTTCTACTTCCCTTAGGCATTTTATAAAAATTTAAAAATTATTTTTCTATTTTGTTTAAAAGA 641 CAATGCATGGCTTTTCAAGTGAGTAATGAAGATAAAAACCAAGCTAGGTTAGTCTACCATTAGTTCATATGTTTTTGTAG 721 CACATCTTTTCATAACATACTGAAATTTTAATGTTTTTTGCCTTTAATAATAGGGGTGAGTGTTAAAGGCCAGAGAGCCT 801 AACTTGATATCTTGCTCATGGTCTTTCTGTCTACCTCAACTCCTGTTGTCATCTTTGGATGATCTTTCTGATACCTTGCT 881 GATACCTTGGACTTCTGCCCAGTGACTTTATTACATTCCAGCAGCTTACTCCCGTGGCCGCACTTTGAATGTCACCACCT 961 TGAGTTTCTCTTTCTGGTAAAATTTCAGTAACTGATAACTGCCCTCTTTTCAGTTTTTTCACTTCCTTATTTTATTGACT 1041 TTTCTCTCCTTTATGCTCATTCCACATTCTTCAGTTCCTTCTTACCCCCTTTTCTTGACTGCTCCCCTTCCTCCTAAACT 1121 GTCAGCCCCTTTCAGGCTTTCTTCCCTATCCACCCTCAGCTTTATGGGATACTATATGAACTAATCTCACCAGTTATTCT 1201 TCTTTCCCTGGTCTTTTAGTCTAGTCCTTTGGCAAGCCCTCAACCTCAGATTAATCCTATTTATTATCTACCTTTTCGGG 1281 GATGCTGAGTTCTTTGTGATGGGTAGTCCTTCAAAGTAGAATCACTACAAGTGTCTCACTTCAGCCTTAGAAAAGCCCTC 1361 AATGTAAACCTTATGTTTGTTACTAGGGTGGCCTCTCTCCCATTTCCCGCTGTGGCTGAGCCAAACTTCATTACTTTCCT 1441 TAGGCCCTCTGCCCCTCCCCTAGCATATGGCTCTTTCTCCTATTGAACAGAAAATTGAGACTATGAAGAGGTCAACTTGT 1521 ATTTACCAACTTTACTCATTTTCCCATTTTAGAGGAAAAGAGGTTGCCTGCTTCCTATCAAAGGCGACTCTGTGCTACAT 1601 GTTGGTTTCATCTTCGCTGTCTCTCTCATTTCCCCACAAAGTGTTGTCTCACTTTCTGCCTACCTTTTAGGTATTGATCT 1681 TCACTATATTTTTTTCTCTCTCTCTCTTTTTTTTTTTTACTTTACATATTTTATACAATGTCATTCATAACTATGGCTTC 1761 TTTTACCACCTGTAATAACAGACTGAGTCTCAAACCTGTAACTTGTATCCTGACTTATCTCTTGCTTTCTAAACCTTGTT 1841 TCTAACTGTCTATCAAATATCTTCATTAGACATCCCACAGTAATTTTAAGCTCAGTGTTTCCAAACGTCAAGTCCTCATC 1921 TGTTATATAAAATCCTTTCTGCTTTGTAAGTTTTCTCTTTTTGGGATTTTCCGCAGATCAGGGCAACACAGAATGACTAC 2001 CTTCCCAGCCATGTCTCTGCAGTCATCCTGTGTAATCATGTTCTAGTCCAGTGTTGCTCAAACAGTTAAAATCCAGGCTG 2081 CTTTTGGTAAACATACAAATTCTGATATAGAGCCTCTGTGGCAAAGGGAATTTCTCAGTTCCTGCCCCAGCCCCCTTGTT 2161 TATCATTACACAGCTAAGATTTTTATTTAACTTAGCATTTTAGCAAGTTTTCTTATGAAAATACCTTTGTGCTTTCTAAG 2241 TATAAAGATTTAAATTATTTTTAATACGGTTTTTAGAACCACAGACTATCCCTCTTTTTAGAGCATCCTGATCAATTGCA 2321 AGTACTTCCACTTCTTCCCTAAATGCGCTTTGTGTGTTTTCCACCTCAGTAGCCTTGCACACATCATTACTTCTGCATCC 2401 TTCTTTGTGACCAAGTGAATACCTACCTACCTCTTAGGACTCAGCTTCAGTGATTCTGTTTTCATAGGCTTTTTAAAGCC 2481 CTTTTCAGTCAAATTAGATGCTCCTTTGTTCTGGTCCTTTACTCTTCCCCTCCCATGTTGTCGCACTGATCACACTGCTT 2561 TGTAATTATTTTCTTTATTGTTGGTAAACTCCATATTTTAAAAATTTACCTGTATACATAGTGCTTAATGCATGGTAGGC 2641 CCTTAGTAATGTTTTTGAATTAATGAGGCATGATTCTAAATGCCAAACTTTGCACAAAAAGTTGTTGCTATTGGATTCCA 2721 AACTGCTATGCCCTCTATACCAGTGGCTGACAAGGCATATAGGGATATATGCCATCCTGAGAGGAGTAAAGTGTTTAGAT 2801 TCTGAACCTGAGAAAAGAGAACTTTCTCTTAAGAAGTTGGAAACTTCATTTTACCTTCGTGACCCTGGTAGACCACTTGG 2881 TCTCACTGGTTGGTACAATTATGAGGGTAGTACTGGGTGCTTTTTATACAACTTTCCATCCCCCACACAGTTGGAGAATA 2961 ATTTGTAGACCATGGCAGTTAAAATGCTTTTTACTCTGGTGTATTATAGAATAATGAACACATTTTTATATATGTTAAAG 3041 CCTGCTAAATCATTCACTTAGAATGAAGTAACCTCAAGGTACCAAATACCCCACATAAGGAAAGTACTACACTAAATTCA 3121 CTCAACTATTGTATGCCTACCATATGCCAGATTTTATCCTAGACCCTGAGGATATAGCTTTTTAAAACCCCCTCCTGTTT 3201 CAGAGCTTATATTCTAGTGGAGGAAGTTAGACAAGCATTTTAAGTAATAAATGTATAGAGAGTGTCAAGTGATGAGTACC 3281 ATGAAGAAGAATAAATGAGGGTAAGGGGCTAGTGTGATAGGGAGAGGGGTGGGATGCCATCATATTTAGGGGTGGTTGGG 3361 AACTGTCTACTGCTTTAGCATTTGTGTCTTCAAATTTCTCTCCTTTGGTTATATACCTTGCGTATTCCGCACATTGATAA 3441 AGTTTCTTTCTTACAGAAGTTCTGATATTGAATTAAGGAATGGGTCACTACTTAAGACTTTATCATTTCAGCTACACATA 3521 AAAGGTTTCTCTCCCCTATGGATTTTGCTAATGGTTGAGTGATACCTAAAGGCCTTGTTGCATTTTTTACACTTGGGGTT 3601 TCTCTTCGGTTTGAATTCTCTCATGGTTACCAAAACTCTGTTAAAGGACTTTTCACAGTCGTTAAATGTGTATGGCTCTT 3681 TCCCAATATGAATTTTTTTGATGTTAACTAGGCTTTTAGACTTAGTTAAAGACCTGTGTGCTCTGCTGCATTTATAGGGT 3761 TTTGGGCTGCTGAGAATAATTGATGCTGATTAAGGTGCAAATCATGACTAAAGACTTTTCTTTCTTCTTTTGCATATAGT 3841 AGAGTGAGGTGAGGGTCGTGGCTAAAACCCCACAATAACTTTACATTCCTAGCTTTACAGTCTTGCTGTGAATTCTCTGG 3921 TGTTCATTAAAGTGTGAGCTGTGTTAAAAGGCATTCTTAGATTCATTTTAACCACATTTTTAAAAACTCACAGTTGGTTA 4001 ACATGATGGTTTCAGATTGCTTGCCTCTTTTCTCTTTCTACCTTACAGGGCTCCTTTTCTAGCTTAAATAAGGGTACTCC 4081 ATCTGCCACAGAATCCAGGATTCTATAGTTTTTTAGTTTCACTTCCCTATGTTCTTTTTTTTTTTTTAATTTTTAACAAT 4161 GAGATGATACCATGTTACAGCGGTATTACATTAAGATACATTTAATATAGCCACAATTAAAGTATGTATTATGTATTTAT 4241 GCTGGTGTTCTTTCATGTTATTTCTTCTAGTGAAAATTTCCAAGTAAACTGTTATTGAGCATATACATTTTTAAAAAAAT 4321 AAAACCATACACCCCTAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
PAR-CLIP data was present in GSM545213. RNA binding protein: AGO2. Condition:Control
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 285636.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 285636.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065667. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065669. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 5 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
Experimental Support 6 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177602. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_4
PAR-CLIP data was present in ERX177604. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_2_6
PAR-CLIP data was present in ERX177600. RNA binding protein: AGO2. Condition:p53_V_Ago_CLIP_2_2
PAR-CLIP data was present in ERX177612. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_2
PAR-CLIP data was present in ERX177622. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_12
PAR-CLIP data was present in ERX177624. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_2
PAR-CLIP data was present in ERX177626. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_4
PAR-CLIP data was present in ERX177634. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_12
PAR-CLIP data was present in ERX177599. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_1
PAR-CLIP data was present in ERX177603. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_5
PAR-CLIP data was present in ERX177606. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_8
PAR-CLIP data was present in ERX177610. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_12
PAR-CLIP data was present in ERX177611. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_1
PAR-CLIP data was present in ERX177614. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_4
PAR-CLIP data was present in ERX177615. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_5
PAR-CLIP data was present in ERX177616. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_6
PAR-CLIP data was present in ERX177618. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_8
PAR-CLIP data was present in ERX177623. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_1
PAR-CLIP data was present in ERX177627. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_5
PAR-CLIP data was present in ERX177629. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_4_7
PAR-CLIP data was present in ERX177630. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_8
PAR-CLIP data was present in ERX177605. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_2_7
PAR-CLIP data was present in ERX177617. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_3_7
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
Experimental Support 7 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760632. RNA binding protein: AGO2. Condition:AGO-CLIP-22RV1_C
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000381647.2 | 3UTR | UCUUUCUGUCUACCUCAACUCCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545213 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000381647.2 | 3UTR | UCUUUCUGUCUACCUCAACUCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000381647.2 | 3UTR | UCUUUCUGUCUACCUCAACU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000381647.2 | 3UTR | UCUUUCUGUCUACCUCAACUCCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000381647.2 | 3UTR | UCUUUCUGUCUACCUCAACUCCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000381647.2 | 3UTR | CUCAUGGUCUUUCUGUCUACCUCAACUCCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000381647.2 | 3UTR | CUUUCUGUCUACCUCAACUCCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM1065667 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_6 |
Location of target site | ENST00000381647.2 | 3UTR | UCUUUCUGUCUACCUCAACUCCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM1065669 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_8 |
Location of target site | ENST00000381647.2 | 3UTR | UCUUUCUGUCUACCUCAACUCCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 10 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000381647.2 | 3UTR | UCUUUCUGUCUACCUCAACUCCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
CLIP-seq Support 11 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000381647.2 | 3UTR | AUAUCUUGCUCAUGGUCUUUCUGUCUACCUCAACUCCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT088097 | SEPT2 | septin 2 | 2 | 2 | ||||||||
MIRT143134 | MGRN1 | mahogunin ring finger 1 | 2 | 2 | ||||||||
MIRT153912 | NCOA3 | nuclear receptor coactivator 3 | 2 | 2 | ||||||||
MIRT154894 | GNAS | GNAS complex locus | 2 | 4 | ||||||||
MIRT200996 | ZNF805 | zinc finger protein 805 | 2 | 2 | ||||||||
MIRT215729 | C5ORF51 | chromosome 5 open reading frame 51 | 2 | 10 | ||||||||
MIRT235593 | POFUT1 | protein O-fucosyltransferase 1 | 2 | 2 | ||||||||
MIRT263250 | SGPL1 | sphingosine-1-phosphate lyase 1 | 2 | 2 | ||||||||
MIRT317951 | CDC5L | cell division cycle 5 like | 2 | 4 | ||||||||
MIRT325572 | HIATL1 | major facilitator superfamily domain containing 14B | 2 | 4 | ||||||||
MIRT354739 | LSM3 | LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated | 2 | 2 | ||||||||
MIRT444552 | UBE2D3 | ubiquitin conjugating enzyme E2 D3 | 2 | 4 | ||||||||
MIRT446978 | SUSD5 | sushi domain containing 5 | 2 | 2 | ||||||||
MIRT451036 | ZNF610 | zinc finger protein 610 | 2 | 2 | ||||||||
MIRT451596 | TRPM7 | transient receptor potential cation channel subfamily M member 7 | 2 | 2 | ||||||||
MIRT452025 | NLRP6 | NLR family pyrin domain containing 6 | 2 | 2 | ||||||||
MIRT452594 | CA6 | carbonic anhydrase 6 | 2 | 2 | ||||||||
MIRT452768 | TCEA3 | transcription elongation factor A3 | 2 | 4 | ||||||||
MIRT452959 | ZNF844 | zinc finger protein 844 | 2 | 2 | ||||||||
MIRT453191 | ACSF2 | acyl-CoA synthetase family member 2 | 2 | 2 | ||||||||
MIRT453382 | RHD | Rh blood group D antigen | 2 | 2 | ||||||||
MIRT453685 | CEBPD | CCAAT/enhancer binding protein delta | 2 | 2 | ||||||||
MIRT455272 | DDX39B | DExD-box helicase 39B | 2 | 8 | ||||||||
MIRT455346 | BAMBI | BMP and activin membrane bound inhibitor | 2 | 2 | ||||||||
MIRT456494 | SERAC1 | serine active site containing 1 | 2 | 2 | ||||||||
MIRT456585 | NID1 | nidogen 1 | 2 | 2 | ||||||||
MIRT456888 | DDA1 | DET1 and DDB1 associated 1 | 2 | 2 | ||||||||
MIRT457123 | APOLD1 | apolipoprotein L domain containing 1 | 2 | 2 | ||||||||
MIRT457852 | ZNF324B | zinc finger protein 324B | 2 | 2 | ||||||||
MIRT457987 | APAF1 | apoptotic peptidase activating factor 1 | 2 | 2 | ||||||||
MIRT459278 | APOBEC3F | apolipoprotein B mRNA editing enzyme catalytic subunit 3F | 2 | 2 | ||||||||
MIRT459625 | SLC25A33 | solute carrier family 25 member 33 | 2 | 2 | ||||||||
MIRT459715 | SGK494 | uncharacterized serine/threonine-protein kinase SgK494 | 2 | 2 | ||||||||
MIRT460057 | RPL22L1 | ribosomal protein L22 like 1 | 2 | 2 | ||||||||
MIRT460182 | UNK | unkempt family zinc finger | 2 | 6 | ||||||||
MIRT460288 | PDE11A | phosphodiesterase 11A | 2 | 2 | ||||||||
MIRT460841 | EGF | epidermal growth factor | 2 | 4 | ||||||||
MIRT460860 | TBC1D19 | TBC1 domain family member 19 | 2 | 2 | ||||||||
MIRT461519 | EMC7 | ER membrane protein complex subunit 7 | 2 | 2 | ||||||||
MIRT461729 | SLC27A1 | solute carrier family 27 member 1 | 2 | 4 | ||||||||
MIRT461821 | SNAP23 | synaptosome associated protein 23 | 2 | 2 | ||||||||
MIRT462066 | CCDC77 | coiled-coil domain containing 77 | 2 | 4 | ||||||||
MIRT462084 | MSANTD2 | Myb/SANT DNA binding domain containing 2 | 2 | 2 | ||||||||
MIRT462508 | MTFMT | mitochondrial methionyl-tRNA formyltransferase | 2 | 10 | ||||||||
MIRT464239 | VCP | valosin containing protein | 2 | 2 | ||||||||
MIRT465316 | TRAF5 | TNF receptor associated factor 5 | 2 | 2 | ||||||||
MIRT466549 | TBL1XR1 | transducin beta like 1 X-linked receptor 1 | 2 | 2 | ||||||||
MIRT467128 | SRGAP1 | SLIT-ROBO Rho GTPase activating protein 1 | 2 | 8 | ||||||||
MIRT468091 | SHCBP1 | SHC binding and spindle associated 1 | 2 | 2 | ||||||||
MIRT469630 | RAD21 | RAD21 cohesin complex component | 2 | 6 | ||||||||
MIRT471097 | PIK3C2B | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | 2 | 2 | ||||||||
MIRT472704 | MYBL1 | MYB proto-oncogene like 1 | 2 | 2 | ||||||||
MIRT472830 | MTMR10 | myotubularin related protein 10 | 2 | 2 | ||||||||
MIRT472872 | MTHFD2 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase | 2 | 2 | ||||||||
MIRT472895 | MTDH | metadherin | 2 | 2 | ||||||||
MIRT473728 | MAPK1 | mitogen-activated protein kinase 1 | 2 | 2 | ||||||||
MIRT473859 | MAP2K4 | mitogen-activated protein kinase kinase 4 | 2 | 2 | ||||||||
MIRT474047 | LONRF1 | LON peptidase N-terminal domain and ring finger 1 | 2 | 2 | ||||||||
MIRT474297 | LAMC1 | laminin subunit gamma 1 | 2 | 2 | ||||||||
MIRT474658 | KLF13 | Kruppel like factor 13 | 2 | 2 | ||||||||
MIRT475234 | IKZF3 | IKAROS family zinc finger 3 | 2 | 2 | ||||||||
MIRT475500 | HSP90B1 | heat shock protein 90 beta family member 1 | 2 | 2 | ||||||||
MIRT475742 | HERPUD1 | homocysteine inducible ER protein with ubiquitin like domain 1 | 2 | 4 | ||||||||
MIRT475793 | HDGF | heparin binding growth factor | 2 | 2 | ||||||||
MIRT477254 | ERGIC2 | ERGIC and golgi 2 | 2 | 2 | ||||||||
MIRT478228 | DDX52 | DExD-box helicase 52 | 2 | 2 | ||||||||
MIRT478393 | DCTN5 | dynactin subunit 5 | 2 | 2 | ||||||||
MIRT478754 | CS | citrate synthase | 2 | 2 | ||||||||
MIRT478827 | CRKL | CRK like proto-oncogene, adaptor protein | 2 | 4 | ||||||||
MIRT480234 | C9orf41 | carnosine N-methyltransferase 1 | 2 | 2 | ||||||||
MIRT480597 | BTRC | beta-transducin repeat containing E3 ubiquitin protein ligase | 2 | 2 | ||||||||
MIRT484121 | C14orf142 | GON7, KEOPS complex subunit homolog | 2 | 2 | ||||||||
MIRT484689 | PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 | 2 | 2 | ||||||||
MIRT486331 | C11orf54 | chromosome 11 open reading frame 54 | 2 | 4 | ||||||||
MIRT488599 | FAM3C | family with sequence similarity 3 member C | 2 | 8 | ||||||||
MIRT488833 | MRRF | mitochondrial ribosome recycling factor | 2 | 2 | ||||||||
MIRT492523 | RAB15 | RAB15, member RAS oncogene family | 2 | 4 | ||||||||
MIRT493632 | HIC2 | HIC ZBTB transcriptional repressor 2 | 2 | 2 | ||||||||
MIRT500026 | ABCF2 | ATP binding cassette subfamily F member 2 | 2 | 8 | ||||||||
MIRT501075 | SMAD7 | SMAD family member 7 | 2 | 8 | ||||||||
MIRT503094 | BTG2 | BTG anti-proliferation factor 2 | 2 | 4 | ||||||||
MIRT503336 | MMAB | methylmalonic aciduria (cobalamin deficiency) cblB type | 2 | 2 | ||||||||
MIRT505465 | STMN1 | stathmin 1 | 2 | 4 | ||||||||
MIRT505726 | SERTAD3 | SERTA domain containing 3 | 2 | 4 | ||||||||
MIRT509333 | MS4A4A | membrane spanning 4-domains A4A | 2 | 2 | ||||||||
MIRT509978 | KCNMB1 | potassium calcium-activated channel subfamily M regulatory beta subunit 1 | 2 | 4 | ||||||||
MIRT513068 | CHST6 | carbohydrate sulfotransferase 6 | 2 | 2 | ||||||||
MIRT513446 | EMP1 | epithelial membrane protein 1 | 2 | 6 | ||||||||
MIRT513736 | PSD3 | pleckstrin and Sec7 domain containing 3 | 2 | 4 | ||||||||
MIRT513996 | CENPQ | centromere protein Q | 2 | 4 | ||||||||
MIRT516538 | MIXL1 | Mix paired-like homeobox | 2 | 2 | ||||||||
MIRT517606 | SAV1 | salvador family WW domain containing protein 1 | 2 | 2 | ||||||||
MIRT518064 | CEP89 | centrosomal protein 89 | 2 | 2 | ||||||||
MIRT518119 | RNMTL1 | mitochondrial rRNA methyltransferase 3 | 2 | 2 | ||||||||
MIRT518325 | WDR92 | WD repeat domain 92 | 2 | 2 | ||||||||
MIRT519048 | ABCB11 | ATP binding cassette subfamily B member 11 | 2 | 2 | ||||||||
MIRT520972 | SPPL2A | signal peptide peptidase like 2A | 2 | 4 | ||||||||
MIRT521359 | RPL35A | ribosomal protein L35a | 2 | 2 | ||||||||
MIRT523359 | GTF3C6 | general transcription factor IIIC subunit 6 | 2 | 2 | ||||||||
MIRT523801 | FAM63A | MINDY lysine 48 deubiquitinase 1 | 2 | 2 | ||||||||
MIRT524622 | C7orf73 | short transmembrane mitochondrial protein 1 | 2 | 2 | ||||||||
MIRT525550 | PHB2 | prohibitin 2 | 2 | 4 | ||||||||
MIRT529709 | ZBTB49 | zinc finger and BTB domain containing 49 | 2 | 2 | ||||||||
MIRT531605 | PLEKHA6 | pleckstrin homology domain containing A6 | 2 | 2 | ||||||||
MIRT532387 | UMPS | uridine monophosphate synthetase | 2 | 2 | ||||||||
MIRT534468 | SCD | stearoyl-CoA desaturase | 2 | 4 | ||||||||
MIRT537546 | ETNK1 | ethanolamine kinase 1 | 2 | 2 | ||||||||
MIRT541619 | C11orf31 | selenoprotein H | 2 | 2 | ||||||||
MIRT548380 | ENPP5 | ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) | 2 | 4 | ||||||||
MIRT549523 | HDDC2 | HD domain containing 2 | 2 | 2 | ||||||||
MIRT549774 | SOD2 | superoxide dismutase 2 | 2 | 2 | ||||||||
MIRT550578 | SLC2A5 | solute carrier family 2 member 5 | 2 | 2 | ||||||||
MIRT551498 | CENPN | centromere protein N | 2 | 4 | ||||||||
MIRT552301 | ITGA3 | integrin subunit alpha 3 | 2 | 2 | ||||||||
MIRT555400 | PPM1L | protein phosphatase, Mg2+/Mn2+ dependent 1L | 2 | 2 | ||||||||
MIRT556399 | LUC7L | LUC7 like | 2 | 2 | ||||||||
MIRT557047 | HOXB3 | homeobox B3 | 2 | 2 | ||||||||
MIRT558072 | ERO1L | endoplasmic reticulum oxidoreductase 1 alpha | 1 | 2 | ||||||||
MIRT559659 | AHCYL2 | adenosylhomocysteinase like 2 | 2 | 2 | ||||||||
MIRT561239 | ZNF354B | zinc finger protein 354B | 2 | 2 | ||||||||
MIRT566899 | LRIG2 | leucine rich repeats and immunoglobulin like domains 2 | 2 | 2 | ||||||||
MIRT568786 | FAM120B | family with sequence similarity 120B | 2 | 2 | ||||||||
MIRT574014 | MRPL12 | mitochondrial ribosomal protein L12 | 2 | 2 | ||||||||
MIRT574885 | Dnajc6 | DnaJ heat shock protein family (Hsp40) member C6 | 2 | 2 | ||||||||
MIRT575243 | Serping1 | serine (or cysteine) peptidase inhibitor, clade G, member 1 | 2 | 2 | ||||||||
MIRT576194 | Vsig2 | V-set and immunoglobulin domain containing 2 | 2 | 2 | ||||||||
MIRT576309 | Acbd7 | acyl-Coenzyme A binding domain containing 7 | 2 | 2 | ||||||||
MIRT576484 | Lhx4 | LIM homeobox protein 4 | 2 | 3 | ||||||||
MIRT576646 | Mill2 | MHC I like leukocyte 2 | 1 | 1 | ||||||||
MIRT576708 | Kras | Kirsten rat sarcoma viral oncogene homolog | 2 | 2 | ||||||||
MIRT576855 | Socs6 | suppressor of cytokine signaling 6 | 2 | 2 | ||||||||
MIRT576950 | Aldoa | aldolase A, fructose-bisphosphate | 2 | 2 | ||||||||
MIRT617133 | ZNF556 | zinc finger protein 556 | 2 | 4 | ||||||||
MIRT617928 | ZNF783 | zinc finger family member 783 | 2 | 2 | ||||||||
MIRT618981 | MRPS16 | mitochondrial ribosomal protein S16 | 2 | 2 | ||||||||
MIRT621100 | SIX3 | SIX homeobox 3 | 2 | 2 | ||||||||
MIRT624537 | BROX | BRO1 domain and CAAX motif containing | 2 | 2 | ||||||||
MIRT625663 | C2orf48 | chromosome 2 open reading frame 48 | 2 | 2 | ||||||||
MIRT627059 | DCTN6 | dynactin subunit 6 | 2 | 2 | ||||||||
MIRT628319 | CLPB | ClpB homolog, mitochondrial AAA ATPase chaperonin | 2 | 2 | ||||||||
MIRT630859 | ENTPD5 | ectonucleoside triphosphate diphosphohydrolase 5 | 2 | 2 | ||||||||
MIRT632295 | TMEM65 | transmembrane protein 65 | 2 | 2 | ||||||||
MIRT634115 | ZNF207 | zinc finger protein 207 | 2 | 2 | ||||||||
MIRT634736 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | 2 | 2 | ||||||||
MIRT635655 | NDST3 | N-deacetylase and N-sulfotransferase 3 | 2 | 2 | ||||||||
MIRT635772 | PDCL3 | phosducin like 3 | 2 | 2 | ||||||||
MIRT635911 | LILRA2 | leukocyte immunoglobulin like receptor A2 | 2 | 2 | ||||||||
MIRT636365 | OGFRL1 | opioid growth factor receptor like 1 | 2 | 4 | ||||||||
MIRT637251 | GLRX2 | glutaredoxin 2 | 2 | 2 | ||||||||
MIRT638705 | FZD4 | frizzled class receptor 4 | 2 | 2 | ||||||||
MIRT639640 | PREX2 | phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2 | 2 | 2 | ||||||||
MIRT639676 | PPEF2 | protein phosphatase with EF-hand domain 2 | 2 | 4 | ||||||||
MIRT642267 | SMIM17 | small integral membrane protein 17 | 2 | 2 | ||||||||
MIRT642372 | ZNF581 | zinc finger protein 581 | 2 | 2 | ||||||||
MIRT643545 | SLC25A17 | solute carrier family 25 member 17 | 2 | 2 | ||||||||
MIRT647994 | PDE12 | phosphodiesterase 12 | 2 | 2 | ||||||||
MIRT649094 | NOM1 | nucleolar protein with MIF4G domain 1 | 2 | 2 | ||||||||
MIRT650993 | ZNF770 | zinc finger protein 770 | 2 | 2 | ||||||||
MIRT651956 | UBE2N | ubiquitin conjugating enzyme E2 N | 2 | 2 | ||||||||
MIRT652977 | SUN2 | Sad1 and UNC84 domain containing 2 | 2 | 2 | ||||||||
MIRT654389 | RBM12B | RNA binding motif protein 12B | 2 | 2 | ||||||||
MIRT655637 | OLFML2A | olfactomedin like 2A | 2 | 2 | ||||||||
MIRT655729 | NRXN3 | neurexin 3 | 2 | 2 | ||||||||
MIRT658171 | FCHSD1 | FCH and double SH3 domains 1 | 2 | 2 | ||||||||
MIRT660937 | ACOX1 | acyl-CoA oxidase 1 | 2 | 2 | ||||||||
MIRT662112 | CERKL | ceramide kinase like | 2 | 2 | ||||||||
MIRT662302 | MPV17L | MPV17 mitochondrial inner membrane protein like | 2 | 2 | ||||||||
MIRT662993 | TMEM59 | transmembrane protein 59 | 2 | 2 | ||||||||
MIRT663071 | SFR1 | SWI5 dependent homologous recombination repair protein 1 | 2 | 2 | ||||||||
MIRT663704 | ABHD17B | abhydrolase domain containing 17B | 2 | 2 | ||||||||
MIRT663864 | MUC20 | mucin 20, cell surface associated | 2 | 2 | ||||||||
MIRT665185 | HAUS5 | HAUS augmin like complex subunit 5 | 2 | 4 | ||||||||
MIRT665402 | WEE1 | WEE1 G2 checkpoint kinase | 2 | 2 | ||||||||
MIRT665688 | TNPO3 | transportin 3 | 2 | 2 | ||||||||
MIRT665795 | TMEM170A | transmembrane protein 170A | 2 | 2 | ||||||||
MIRT665847 | TIAL1 | TIA1 cytotoxic granule associated RNA binding protein like 1 | 2 | 2 | ||||||||
MIRT666999 | PDPN | podoplanin | 2 | 2 | ||||||||
MIRT667598 | LIPC | lipase C, hepatic type | 2 | 2 | ||||||||
MIRT668576 | ELMSAN1 | ELM2 and Myb/SANT domain containing 1 | 2 | 4 | ||||||||
MIRT670960 | UGGT1 | UDP-glucose glycoprotein glucosyltransferase 1 | 2 | 2 | ||||||||
MIRT671187 | ZNF891 | zinc finger protein 891 | 2 | 2 | ||||||||
MIRT671739 | ZNF451 | zinc finger protein 451 | 2 | 2 | ||||||||
MIRT672745 | ZNF585B | zinc finger protein 585B | 2 | 4 | ||||||||
MIRT673446 | ZNF583 | zinc finger protein 583 | 2 | 2 | ||||||||
MIRT679843 | GPR75 | G protein-coupled receptor 75 | 2 | 2 | ||||||||
MIRT680556 | ZNF584 | zinc finger protein 584 | 2 | 2 | ||||||||
MIRT680661 | C1orf210 | chromosome 1 open reading frame 210 | 2 | 2 | ||||||||
MIRT681285 | RFC2 | replication factor C subunit 2 | 2 | 2 | ||||||||
MIRT683264 | ZNF329 | zinc finger protein 329 | 2 | 2 | ||||||||
MIRT684519 | C1orf174 | chromosome 1 open reading frame 174 | 2 | 2 | ||||||||
MIRT685065 | GEMIN4 | gem nuclear organelle associated protein 4 | 2 | 2 | ||||||||
MIRT685157 | DTWD2 | DTW domain containing 2 | 2 | 2 | ||||||||
MIRT685168 | ERCC1 | ERCC excision repair 1, endonuclease non-catalytic subunit | 2 | 2 | ||||||||
MIRT685470 | CACNG8 | calcium voltage-gated channel auxiliary subunit gamma 8 | 2 | 2 | ||||||||
MIRT686001 | NEK4 | NIMA related kinase 4 | 2 | 2 | ||||||||
MIRT687027 | RNF24 | ring finger protein 24 | 2 | 2 | ||||||||
MIRT687543 | MOB1B | MOB kinase activator 1B | 2 | 2 | ||||||||
MIRT687592 | MANEAL | mannosidase endo-alpha like | 2 | 2 | ||||||||
MIRT687753 | KIAA1328 | KIAA1328 | 2 | 2 | ||||||||
MIRT688050 | GLUL | glutamate-ammonia ligase | 2 | 2 | ||||||||
MIRT688374 | ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT688802 | CBFA2T3 | CBFA2/RUNX1 translocation partner 3 | 2 | 2 | ||||||||
MIRT688957 | ATXN3 | ataxin 3 | 2 | 2 | ||||||||
MIRT689281 | C5AR2 | complement component 5a receptor 2 | 2 | 2 | ||||||||
MIRT689988 | NNMT | nicotinamide N-methyltransferase | 2 | 2 | ||||||||
MIRT689997 | MMP17 | matrix metallopeptidase 17 | 2 | 2 | ||||||||
MIRT690014 | LUZP2 | leucine zipper protein 2 | 2 | 2 | ||||||||
MIRT690161 | ELP3 | elongator acetyltransferase complex subunit 3 | 2 | 2 | ||||||||
MIRT690379 | ZSWIM7 | zinc finger SWIM-type containing 7 | 2 | 2 | ||||||||
MIRT690563 | MICA | MHC class I polypeptide-related sequence A | 2 | 2 | ||||||||
MIRT691891 | EVC | EvC ciliary complex subunit 1 | 2 | 2 | ||||||||
MIRT693107 | SCNM1 | sodium channel modifier 1 | 2 | 2 | ||||||||
MIRT693832 | ZFP64 | ZFP64 zinc finger protein | 2 | 2 | ||||||||
MIRT694105 | ZNF446 | zinc finger protein 446 | 2 | 2 | ||||||||
MIRT694179 | ZNF486 | zinc finger protein 486 | 2 | 2 | ||||||||
MIRT694475 | LRTOMT | leucine rich transmembrane and O-methyltransferase domain containing | 2 | 2 | ||||||||
MIRT694998 | GGA2 | golgi associated, gamma adaptin ear containing, ARF binding protein 2 | 2 | 2 | ||||||||
MIRT695031 | ALG10B | ALG10B, alpha-1,2-glucosyltransferase | 2 | 2 | ||||||||
MIRT695163 | TCTN2 | tectonic family member 2 | 2 | 2 | ||||||||
MIRT695525 | SLC25A34 | solute carrier family 25 member 34 | 2 | 2 | ||||||||
MIRT696067 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT696616 | CRIPT | CXXC repeat containing interactor of PDZ3 domain | 2 | 2 | ||||||||
MIRT696661 | AGXT2 | alanine--glyoxylate aminotransferase 2 | 2 | 2 | ||||||||
MIRT696705 | PNPO | pyridoxamine 5'-phosphate oxidase | 2 | 2 | ||||||||
MIRT697173 | INMT | indolethylamine N-methyltransferase | 2 | 2 | ||||||||
MIRT697303 | ZNF652 | zinc finger protein 652 | 2 | 2 | ||||||||
MIRT697491 | ZBTB8B | zinc finger and BTB domain containing 8B | 2 | 2 | ||||||||
MIRT698657 | TERF2 | telomeric repeat binding factor 2 | 2 | 2 | ||||||||
MIRT699042 | SOAT1 | sterol O-acyltransferase 1 | 2 | 2 | ||||||||
MIRT699185 | SLX4IP | SLX4 interacting protein | 2 | 2 | ||||||||
MIRT699598 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 2 | ||||||||
MIRT700150 | RNF115 | ring finger protein 115 | 2 | 2 | ||||||||
MIRT700720 | PNO1 | partner of NOB1 homolog | 2 | 2 | ||||||||
MIRT700870 | PER2 | period circadian clock 2 | 2 | 2 | ||||||||
MIRT700912 | PDXK | pyridoxal kinase | 2 | 2 | ||||||||
MIRT701095 | PAPOLG | poly(A) polymerase gamma | 2 | 2 | ||||||||
MIRT701194 | OTUD3 | OTU deubiquitinase 3 | 2 | 2 | ||||||||
MIRT702203 | LPP | LIM domain containing preferred translocation partner in lipoma | 2 | 2 | ||||||||
MIRT702272 | LHX4 | LIM homeobox 4 | 2 | 3 | ||||||||
MIRT703125 | GPRC5A | G protein-coupled receptor class C group 5 member A | 2 | 2 | ||||||||
MIRT703252 | GNS | glucosamine (N-acetyl)-6-sulfatase | 2 | 2 | ||||||||
MIRT703262 | GNL3L | G protein nucleolar 3 like | 2 | 2 | ||||||||
MIRT703440 | FYTTD1 | forty-two-three domain containing 1 | 2 | 2 | ||||||||
MIRT704321 | DCUN1D5 | defective in cullin neddylation 1 domain containing 5 | 2 | 2 | ||||||||
MIRT704393 | CTSS | cathepsin S | 2 | 2 | ||||||||
MIRT704483 | CPT1A | carnitine palmitoyltransferase 1A | 2 | 2 | ||||||||
MIRT704880 | CCSER2 | coiled-coil serine rich protein 2 | 2 | 2 | ||||||||
MIRT704926 | CCDC36 | coiled-coil domain containing 36 | 2 | 2 | ||||||||
MIRT705175 | BZW1 | basic leucine zipper and W2 domains 1 | 2 | 2 | ||||||||
MIRT706561 | EIF2AK2 | eukaryotic translation initiation factor 2 alpha kinase 2 | 2 | 2 | ||||||||
MIRT707048 | TRPV2 | transient receptor potential cation channel subfamily V member 2 | 2 | 2 | ||||||||
MIRT711497 | PGD | phosphogluconate dehydrogenase | 2 | 2 | ||||||||
MIRT716644 | EPGN | epithelial mitogen | 2 | 2 | ||||||||
MIRT720083 | TNRC6B | trinucleotide repeat containing 6B | 2 | 2 | ||||||||
MIRT722288 | PMPCA | peptidase, mitochondrial processing alpha subunit | 2 | 2 | ||||||||
MIRT725468 | GRAP2 | GRB2-related adaptor protein 2 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|